Oneview Healthcare ties up with Oxford University for R&D

Company News

by Jessica Ellerm

Oneview Healthcare (ASX:ONE) has announced it has formed a 5-year R&D partnership with The University of Oxford and Oxford University Hospital NHS Foundation Trust.

The partnership will continue research and development on a clinical pathways product.

The catalyst for the R&D tie-up was the success of an earlier pilot into digital pathways for prostate cancer to improve patient outcomes and deliver cost efficiencies to health systems
.
The new research will focus on expanding the technology to include full commercial deployment at Oxford and expansion of scope into other types of cancer.

Oneview Healthcare (ASX:ONE) was trading around 1.98 % higher this morning at $2.06.
 

Jessica Ellerm

Finance News Network
Jessica joined FNN in April 2016 and presents the Australian Share Market Outlook, and reports on the morning's leading business stories. Alongside FNN Jessica is a fintech industry commentator, writing for her own blog and a number of international online publications.